drugset / Trial / NCT04422561
Prophylactic Ivermectin in COVID-19 Contacts
RandomizedSequentialOpen-labelPrevention
Summary
asymptomatic family close contact of confirmed COVID -19 patient will receive prophylactic ivermectin and will be followed up for 14 days for any symptoms \& diagnosis of COVID -19
Timeline
- Start
- 2020-05-31
- Primary completion
- 2020-07-14
- Completion
- 2020-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivermectin | Small molecule | — | — |